With ‘Schedule M’ coming into effect to improve the quality of India-made medicines, the drug regulator has now instructed officers across the country to begin audits of drug-making units to ensure they are meeting the new standards. Alongside this, the drug regulatory agency Central Drugs Standard Control Organisation has made Schedule M compliance mandatory for issuing new manufacturing licenses and …
